News

April 14, 2016

Halo Pharmaceutical and ExxPharma Therapeutics to Collaborate on the Development/Manufacturing of Products using Twin Screw Extrusion Technology

ExxPharma Therapeutics LLC (“ExxPharma”) and Halo Pharmaceutical Inc. (“Halo”) have entered into a collaboration agreement to develop and manufacture drug products for customers of Halo and ExxPharma using ExxPharma’s innovative drug delivery systems and twin screw extrusion-based manufacturing technology.

Read More
August 25, 2015

Halo Pharma Makes Key Additions To Management Team

Halo Pharma, a rapidly growing Contract Development and Manufacturing Organization (CDMO) is pleased to announce the appointments of Lee Karras as its Chief Executive Officer and Barry Lederman as its Chief Financial Officer.

Read More
January 6, 2015

SK Capital Makes Strategic Investment in Halo Pharma.

SK Capital Partners, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced today that it has completed a controlling strategic growth investment in Halo Pharma, a premiere provider of outsourced development and manufacturing services to the global pharmaceutical industry. The strategic investment is consistent with SK Capital's sector-focused strategy of investing in niche market leaders with strong brands and technologies and actively supporting management in building thriving businesses with sustainable competitive advantages. Halo Pharma is the sixth platform company in SK Capital Partners Fund III.

Read More
August 1, 2012

Halo Pharma Completes Acquisition of Mirabel (Montreal, Quebec) Facility from Teva Canada.

Teva Canada and Halo Pharma announced today that they have completed the sale of Teva's Mirabel (Montreal, Quebec) manufacturing facility to Halo Pharma.

Read More